New vaccine could protect against COVID-19 variants before they emerge
According to a news release from Caltech, the vaccine works by using spike proteins from SARS-CoV-2 — the virus that causes COVID-19 — and seven other related animal viruses with the potential to cause a pandemic in humans.
The team of researchers is currently testing the new vaccine on mice and monkeys with plans for a Phase 1 human clinical trial.
https://www.ktvu.com/news/caltech-coronavirus-vaccine-nanoparticle-covid-sars-mers